Market Access/ News/ News Astellas buys eye gene therapy biotech Quethera for $109m Piotr Wnuk Astellas, gene therapy, glaucoma, ocular disorders, ophthalmology, Quethera 0 Comment Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused Share X Astellas buys eye gene therapy biotech Quethera for $109m https://pharmaphorum.com/news/astellas-expands-ocular-gene-therapy-investment/
Astellas, gene therapy, glaucoma, ocular disorders, ophthalmology, Quethera
0 Comment
